Patient-Friendly Explanation
Sibutramine is an older weight-loss medicine that worked by reducing appetite. It was taken off the market in many countries after a large study found it raised the risk of heart attacks and strokes in some people. It is a good reminder of why weight-loss medicines must be carefully tested for safety.
Clinical Definition
Sibutramine is a serotonin-noradrenaline reuptake inhibitor that was used as an anti-obesity agent to promote satiety and increase energy expenditure. It was withdrawn in most countries following the SCOUT trial, which demonstrated an increased risk of non-fatal myocardial infarction and stroke in patients with pre-existing cardiovascular disease.
Why It Matters
Understanding why medications like sibutramine were withdrawn highlights the importance of medically supervised treatment. NuLifeCare Singapore only offers evidence-based, safety-tested weight management options under medical supervision.